In contrast to the activation of canonical Wnt signaling in ovarian cancer cells with functional BRCA1 and BRCA2, our results show that loss of BRCA1 leads to the activation of the noncanonical Wnt signaling pathway in response to Wnt3A. The gene discussed is BRCA2; the disease is ovarian carcinoma.